Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Temporal manipulation of Cdkl5 reveals essential postdevelopmental functions and reversible CDKL5 deficiency disorder–related deficits
Barbara Terzic, M. Felicia Davatolhagh, Yugong Ho, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 20
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Insights from a 30-year journey: function, regulation and therapeutic modulation of PD1
Kenji Chamoto, Tomonori Yaguchi, Masaki Tajima, et al.
Nature reviews. Immunology (2023) Vol. 23, Iss. 10, pp. 682-695
Closed Access | Times Cited: 92
Single-cell technology grows up: Leveraging high-resolution omics approaches to understand neurodevelopmental disorders
Joseph D. Dougherty, Simona Sarafinovska, Sneha Chaturvedi, et al.
Current Opinion in Neurobiology (2025) Vol. 92, pp. 102990-102990
Open Access | Times Cited: 1
De novo variants in CDKL1 and CDKL2 are associated with neurodevelopmental symptoms
Ali Hosseini Bereshneh, Jonathan C. Andrews, Daniel F. Eberl, et al.
The American Journal of Human Genetics (2025)
Closed Access | Times Cited: 1
CDKL5 deficiency disorder: molecular insights and mechanisms of pathogenicity to fast-track therapeutic development
Nicole J. Van Bergen, Sean Massey, Anita Quigley, et al.
Biochemical Society Transactions (2022) Vol. 50, Iss. 4, pp. 1207-1224
Open Access | Times Cited: 31
Cell type-specific expression, regulation and compensation of CDKL5 activity in mouse brain
Margaux Silvestre, Kelvin Dempster, Simeon R. Mihaylov, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 6, pp. 1844-1856
Open Access | Times Cited: 8
CDKL5 Deficiency Disorder-Related Epilepsy: A Review of Current and Emerging Treatment
William Hong, Isabel Haviland, Elia M. Pestana-Knight, et al.
CNS Drugs (2022) Vol. 36, Iss. 6, pp. 591-604
Open Access | Times Cited: 24
Midbrain dopamine neurons arbiter OCD-like behavior
Jinwen Xue, Dandan Qian, Bing-Qian Zhang, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 46
Open Access | Times Cited: 24
Epilepsy-Related CDKL5 Deficiency Slows Synaptic Vesicle Endocytosis in Central Nerve Terminals
Christiana Kontaxi, Daniela Ivanova, Elizabeth C. Davenport, et al.
Journal of Neuroscience (2023) Vol. 43, Iss. 11, pp. 2002-2020
Open Access | Times Cited: 14
USP27Xvariants underlying X-linked intellectual disability disrupt protein function via distinct mechanisms
I Koch, Maya Slovik, Yuling Zhang, et al.
Life Science Alliance (2024) Vol. 7, Iss. 3, pp. e202302258-e202302258
Open Access | Times Cited: 5
Touchscreen cognitive deficits, hyperexcitability and hyperactivity in males and females using two models ofCdkl5deficiency
Anna Adhikari, Fiona K B Buchanan, Timothy A. Fenton, et al.
Human Molecular Genetics (2022) Vol. 31, Iss. 18, pp. 3032-3050
Open Access | Times Cited: 20
CDKL5 sculpts functional callosal connectivity to promote cognitive flexibility
Patricia N. Awad, Valerio Zerbi, Erin Johnson‐Venkatesh, et al.
Molecular Psychiatry (2023) Vol. 29, Iss. 6, pp. 1698-1709
Open Access | Times Cited: 12
Allelic contribution of Nrxn1α to autism-relevant behavioral phenotypes in mice
Bing Xu, Yugong Ho, Maria Fasolino, et al.
PLoS Genetics (2023) Vol. 19, Iss. 2, pp. e1010659-e1010659
Open Access | Times Cited: 12
Comparison of evoked potentials across four related developmental encephalopathies
Joni N. Saby, Sarika U. Peters, Tim A. Benke, et al.
Journal of Neurodevelopmental Disorders (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin-dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiology
Anna Castano, Margaux Silvestre, Carrow I. Wells, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 12
Variable expression of MECP2, CDKL5, and FMR1 in the human brain: Implications for gene restorative therapies
Antonino Zito, Jeannie T. Lee
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 9
Open Access | Times Cited: 4
The dual role of PTPN22 in immune modulation and transplantation tolerance
Beyza Göncü, Ali Osman Gürol
Human Cell (2025) Vol. 38, Iss. 2
Closed Access
Independent genetic strategies define the scope and limits of CDKL5 deficiency disorder reversal
Xi-E Song, Zijie Xia, Dayne Martinez, et al.
Cell Reports Medicine (2025), pp. 101926-101926
Open Access
Women With Genetic Epilepsies
Paula Marques, Nagham Kaka, Quratulain Zulfiqar Ali, et al.
Neurology Genetics (2025) Vol. 11, Iss. 1
Open Access
Discovery of a Potent and Selective CDKL5/GSK3 Chemical Probe That Is Neuroprotective
Han Wee Ong, Yi Liang, William Richardson, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 9, pp. 1672-1685
Open Access | Times Cited: 10
Preclinical studies of gene replacement therapy for CDKL5 deficiency disorder
Gregory Voronin, Jana Narasimhan, Jamila Gittens, et al.
Molecular Therapy (2024) Vol. 32, Iss. 10, pp. 3331-3345
Closed Access | Times Cited: 3
Acute MeCP2 loss in adult mice reveals transcriptional and chromatin changes that precede neurological dysfunction and inform pathogenesis
Sameer S. Bajikar, Jian Zhou, Ryan O’Hara, et al.
Neuron (2024)
Open Access | Times Cited: 3
Epilepsy-linked kinase CDKL5 phosphorylates voltage-gated calcium channel Cav2.3, altering inactivation kinetics and neuronal excitability
Marisol Sampedro Castañeda, Lucas L. Baltussen, André T. Lopes, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Ganaxolone: First FDA-approved Medicine for the Treatment of Seizures Associated with Cyclin-dependent Kinase-like 5 Deficiency Disorder
Surya K. De
Current Medicinal Chemistry (2023) Vol. 31, Iss. 4, pp. 388-392
Closed Access | Times Cited: 7
CDKL5 deficiency in adult glutamatergic neurons alters synaptic activity and causes spontaneous seizures via TrkB signaling
Zi‐Ai Zhu, Yi‐Yan Li, Juan Xu, et al.
Cell Reports (2023) Vol. 42, Iss. 10, pp. 113202-113202
Open Access | Times Cited: 7
Behavioral impulsivity is associated with pupillary alterations and hyperactivity in CDKL5 mutant mice
Aurelia Viglione, Giulia Sagona, Fabio Carrara, et al.
Human Molecular Genetics (2022) Vol. 31, Iss. 23, pp. 4107-4120
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top